Inicio › Diabetes tipo 2 › Illinois

Ensayos clínicos de Diabetes tipo 2 en Illinois

32 estudios sobre Diabetes tipo 2 buscan participantes en Illinois.

Ciudades en Illinois

Texto oficial del estudio (inglés)

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Evanston Premier Healthcare Research LLC, Skokie

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07754461

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Cedar Crosse Research Center, Chicago
Accellacare of Duly - Lombard, Lombard
Accellacare of Duly, Oak Lawn

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07064473

A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants

Research Site, Chicago

ReclutandoFase 1Se aceptan voluntarios sanos

Edades de 18 a 75 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07024823

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Champaign
Research Site, Chicago

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07776509

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Central Illinois Diabetes and Clinical Research, Springfield

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351058

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Cedar Crosse Research Center, Chicago
Northwestern University, Chicago
Endeavor Health - Family Medicine Administration, Evanston
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

NorthShore University Health System, Skokie

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07282600

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Accellacare - DuPage, Lombard

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07783802

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Research Site, Chicago
Research Site, Skokie

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07662109

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Chicago
Research Site, Melrose Park
Research Site, Oak Brook

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT07784270

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Research by Design, LLC - Internal Medicine, Chicago

ReclutandoFase 2

Edades de 18 a 80 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Research Site, Melrose Park

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT07662213

Achieving Routine Intervention and Screening for Emotional Health

University of Chicago, Chicago

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 oct 2026 · NCT06887049

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Charter Research - Chicago, Chicago

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 19 oct 2026 · NCT07527650

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

SIU Medicine, Springfield

ReclutandoFase 3

Edades de 10 a 18 · Todos los sexos · Actualizado el 19 oct 2026 · NCT07282613

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Chicago Clinical Research Institute, Chicago

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 oct 2026 · NCT07296484

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Endeavor Health, Skokie

ReclutandoFase 3

Edades de 18 a 99 · Todos los sexos · Actualizado el 5 oct 2026 · NCT07684144

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Endeavor Health, Skokie

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07817251

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Northwestern University, Chicago
Northshore University Health System, Glenview

ReclutandoSe aceptan voluntarios sanos

Edades de 55 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06112418

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Schaumburg

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743450

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Cedar-Crosse Research Center, Chicago

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07415954

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Research Site, Chicago

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT07662135

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Elevate Clinical Research, Gurnee
Chicago Medical Research LLC, Hazel Crest
Genesis Orthopedics & Sports Medicine, Oak Brook
y 1 más

ReclutandoFase 3

Edades de 45 en adelante · Todos los sexos · Actualizado el 1 sept 2026 · NCT07797335

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Research Site, Melrose Park

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 ago 2026 · NCT07606066

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

University of Illinois at Chicago, Chicago

ReclutandoFase 3

Edades de 10 a 17 · Todos los sexos · Actualizado el 7 ago 2026 · NCT06739122

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

Northwestern University, Chicago

Reclutando

Edades de 18 a 75 · Todos los sexos · Actualizado el 3 ago 2026 · NCT07521475

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

Northwestern University, Chicago

Reclutando

Edades de 14 a 75 · Todos los sexos · Actualizado el 3 ago 2026 · NCT07579702

Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes

Illinois Institute of Technology, Chicago

ReclutandoEstudio observacional

Edades de 18 a 65 · Todos los sexos · Actualizado el 16 jun 2026 · NCT07650682

Exercise and Protein Efficiency in T2D

Freer Hall - University of Illinois, Urbana

ReclutandoSe aceptan voluntarios sanos

Edades de 65 en adelante · Todos los sexos · Actualizado el 29 abr 2026 · NCT07477067

Enhancing Diabetes Care: Exposome &Amp; Sensors

University of Illinois - Chicago, Chicago
University of Illinois College of Nursing, Chicago

ReclutandoEstudio observacional

Edades de 18 a 65 · Todos los sexos · Actualizado el 25 may 2025 · NCT06989008

My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes

University of Illinois at Chicago, Chicago

ReclutandoSe aceptan voluntarios sanos

Edades de 21 a 75 · Todos los sexos · Actualizado el 5 mar 2025 · NCT05208164

RCT Glargine vs NPH for Treatment of DM in Pregnancy

Loyola University Medical Center, Maywood

ReclutandoFase 3

Edades de 18 en adelante · Mujeres · Actualizado el 1 oct 2024 · NCT06619301

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.